CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
INTELLECTUAL DISABILITY AND OVER-GROWTH -- A CASE CAUSED BY NOVEL MUTATION OF NFIX GENE BASED ON WHOLE-EXON SEQUENCING 会议论文
作者:  Lu, Wei;  Wu, Bing-Bing;  Zhang, Ping;  Wang, Hui-Jun;  Yang, Lin
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
SLC/CCR7 enhances the maturation of semi-mature BMDCs by the pNF-kappa B p65 pathway 会议论文
作者:  Liang, Chun-min;  Zhou, Shuang;  Wu, Wen-qing;  Zhong, Cui-ping
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace